Video Experimental Relacionado
Updated: Apr 13, 2026

14:10
Isometric and Eccentric Force Generation Assessment of Skeletal Muscles Isolated from Murine Models of Muscular Dystrophies
Published on: January 31, 2013
34.2K
Las mutaciones en la enzima proteolítica calpain 3 causan distrofia muscular de cintura y extremidad tipo 2A
I Richard1, O Broux, V Allamand
1Généthon, Evry, France.
Cell
|April 7, 1995
Resumen
Las mutaciones genéticas en el gen calpain 3 (CANP3) causan distrofia muscular del cinturón de las extremidades tipo 2A (LGMD2A). Estos hallazgos sugieren que un defecto enzimático, no estructural, puede ser la causa de esta distrofia muscular.
Área de la Ciencia:
- Genética La genética.
- Biología Molecular Biología Molecular
- Neurología Neurología.
Sus antecedentes:
- Las distrofias musculares del cinturón de extremidades (LGMD) son trastornos hereditarios que afectan la fuerza y la función muscular.
- Las causas genéticas de muchas formas de LGMD siguen siendo desconocidas.
- La LGMD autosómica recesiva (LGMD2) es genéticamente diversa, con LGMD2A vinculado al cromosoma 15q15.1-q21.1.1.
Objetivo del estudio:
- Para identificar la base genética de LGMD2A.
- Para investigar el papel del gen calpain 3 (CANP3) en la patogénesis de LGMD2A.
- Para explorar la herencia digenética potencial en poblaciones aisladas.
Principales métodos:
- Análisis de vínculos genéticos para mapear el locus LGMD2A.
- Cribado de mutación del gen CANP3 en familias afectadas.
- Análisis de la segregación de mutaciones y patrones de herencia.
Principales resultados:
- El gen de la proteasa 3 neutra activada por calcio específica del músculo (CANP3) se localizó en la región crítica LGMD2A.
- Se descubrió que quince mutaciones distintas (sin sentido, sitio de empalme, cambio de marco, falta de sentido) en el gen CANP3 se segregan conjuntamente con LGMD2A.
- Seis de estas mutaciones fueron identificadas en pacientes de la isla de La Reunión, lo que sugiere un modelo de herencia digenética.
Conclusiones:
- Las mutaciones en el gen CANP3 son una causa de LGMD2A.
- LGMD2A resulta de un defecto enzimático en CANP3, en lugar de una anormalidad de la proteína estructural.
- Este defecto enzimático puede afectar las vías de señalización celular, contribuyendo a la degeneración muscular.
Videos de Conceptos Relacionados
Lysosomal Hydrolases
4.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.8K
Satellite Stem Cells and Muscular Dystrophy
2.6K
Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...
2.6K
Calmodulin-dependent Signaling
7.2K
Calmodulin (CaM) is a calcium-binding protein in eukaryotes that controls various calcium-regulated cellular processes. It has four calcium-binding sites that bind calcium to form the calcium-calmodulin ( Ca2+-CaM) complex. GPCR stimulation increases the calcium levels in the cells that bind to CaM and induces a conformational change.
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
The Ca2+-CaM complex does not have enzymatic activity by itself. Instead, the complex binds downstream target proteins, including membrane proteins or enzymes,...
7.2K
Cardiomyopathy III: Hypertrophic Cardiomyopathy
767
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
767

